(Q52868857)
Statements
[Advantages and problems of multicenter therapy studies exemplified by a study of the treatment of metastasizing renal cell carcinoma with recombinant interferon-alpha-2c]. (English)
D Messerer
F Porzsolt
J Hasford
A Neiss
1 February 1987
10
1
43-49